Bessemer Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
6,807
-2,920
-30% -$192K ﹤0.01% 1202
2026
Q1
$692K Buy
9,727
+1,470
+18% +$116K ﹤0.01% 1044
2025
Q4
$678K Buy
8,257
+1,333
+19% +$104K ﹤0.01% 1057
2025
Q3
$520K Buy
6,924
+1,019
+17% +$76K ﹤0.01% 841
2025
Q2
$437K Sell
5,905
-766
-11% -$53.3K ﹤0.01% 865
2025
Q1
$538K Buy
6,671
+1,306
+24% +$112K ﹤0.01% 855
2024
Q4
$419K Sell
5,365
-267
-5% -$22.7K ﹤0.01% 925
2024
Q3
$528K Buy
5,632
+413
+8% +$34.7K ﹤0.01% 882
2024
Q2
$406K Buy
5,219
+576
+12% +$47K ﹤0.01% 852
2024
Q1
$421K Sell
4,643
-650
-12% -$54.1K ﹤0.01% 849
2023
Q4
$409K Buy
5,293
+208
+4% +$14.6K ﹤0.01% 874
2023
Q3
$348K Sell
5,085
-921
-15% -$67K ﹤0.01% 901
2023
Q2
$488K Buy
6,006
+405
+7% +$32.3K ﹤0.01% 822
2023
Q1
$461K Buy
+5,601
New +$400K ﹤0.01% 746

Other funds holding GEHC

Bessemer Group's GEHC Position: Q2 2026 in Review

Bessemer Group reduced its GE HealthCare (GEHC) stake by 30% in Q2 2026, selling an estimated $192K and leaving 6,807 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #1202.

Bessemer Group first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $692K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bessemer Group held 6,807 shares of GE HealthCare worth $436K as of Q2 2026.
  • Bessemer Group sold 2,920 GE HealthCare shares in Q2 2026, an estimated $192K.
  • GE HealthCare made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1202 holding.
  • Bessemer Group first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bessemer Group's GE HealthCare position peaked at $692K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.